Investigators compared oncologic outcomes among patients with tumors in the bladder only vs in the bladder neck/urethra.

Approximately 10 percent of patients with hematuria will be found to have a bladder tumor. Frequently, however, urine that appears perfectly normal to the naked eye will be shown by the microscope to ...

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

The subtypes investigated in bladder cancer were CK19 ... information about the quality of lymph node sample along with tumor burden. Although not uniformly accepted, this index is the most ...

UroGen Pharma's potential remains strong despite market volatility, with promising FDA prospects for UGN-102 & a $5B ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, will announce new clinical findings for ANKTIVA® ...

This ability to move allows them to be distributed more efficiently in the bladder, reaching tumor cells more precisely and ...

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods ...

researchers developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy. The model harnesses whole-slide tumor imaging data and ...

A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.